Scientist working at a microscope in a laboratory

Regulatory risk,

reduced.

reduced.

For medical device and IVD companies. We reduce the risk that a 483, a Warning Letter, or a delayed clearance ever reaches your desk.

Scientist working at a microscope in a laboratory

Regulatory risk,

reduced.

reduced.

For medical device and IVD companies. We reduce the risk that a 483, a Warning Letter, or a delayed clearance ever reaches your desk.

Regulatory risk,

reduced.

reduced.

For medical device and IVD companies. We reduce the risk that a 483, a Warning Letter, or a delayed clearance ever reaches your desk.

In quality and regulatory, the expensive mistakes are quiet ones.

Nothing announces itself. The evidence existed, the reasoning existed, and nobody had time to assemble either under pressure.

One letter can cost a market

Inspection

A 483 observation costs time and money, can escalate to a Warning Letter, and becomes a public record that follows the site for years.

A submission does not fail loudly

Submission

Deficiencies surface weeks after filing, when the fix is expensive and the launch date has already been communicated.

Exposure builds between audits

Quality system

A quality system drifts quietly. The gap is rarely discovered by the people who own it.

One letter can cost a market

Inspection

A 483 observation costs time and money, can escalate to a Warning Letter, and becomes a public record that follows the site for years.

A submission does not fail loudly

Submission

Deficiencies surface weeks after filing, when the fix is expensive and the launch date has already been communicated.

Exposure builds between audits

Quality system

A quality system drifts quietly. The gap is rarely discovered by the people who own it.

Three disciplines. One standard of evidence.

VeraInspect duotone product icon

VeraInspect

VeraInspect duotone product icon

VeraInspect

VeraRespond duotone product icon

VeraRespond

VeraRespond duotone product icon

VeraRespond

VeraClear duotone product icon

VeraClear

Disciplines

Mock inspection. Finding response. Submission review. Each asks the question a regulator will ask, before the regulator asks it.

VeraInspectVeraRespondVeraClearHUMANREVIEWDEFENSIBLEEVIDENCEVeraInspectVeraRespondVeraClearHUMAN REVIEWDEFENSIBLEEVIDENCE

FOUNDER PORTRAIT

Close-up abstract image of translucent gel or oil bubbles suspended in liquid, creating a scientific and artistic texture.

why this exists

Judgment that scales.

The best regulatory judgment in a company usually lives in one or two people, and it does not scale. VIQERA makes it consistent and available, without diluting it.

Founder — Mario Wijker

25+ years in quality and regulatory leadership

Previously: Boston Scientific, Bio-Rad, Teleflex, Mölnlycke, and Life Technologies

ISO 13485 Lead Auditor, FDA QMSR, and AAMI Faculty Board

The judgment of senior inspectors and reviewers, on demand. Each discipline asks the question a regulator will ask, before the regulator asks it.

Mock Inspection

An adversarial mock inspection run against your quality system. You see the 483 the way the agency would write it, while there is still time to answer it. QMSR, ISO 13485, IVDR and MDR.

Icon

Finding Response

Responses to 483 observations, Warning Letters and Notified Body nonconformances, written to close the finding, not restate it.

Icon

Submission Review

A 510(k) reviewed the way an OPEQ reviewer reviews it, at refuse to accept and at substantive review. Deficiency risk surfaced before the submission leaves your hands.

Icon

Named Review

Every consequential output is reviewed by a qualified subject matter expert before release.

Icon

Traceable Reasoning

Reasoning, sources and limitations are visible on the output, not held behind it.

Icon

Confidential by Default

Your records stay yours. Engagements are confidential and scoped in writing.

The judgment of senior inspectors and reviewers, on demand. Each discipline asks the question a regulator will ask, before the regulator asks it.

Mock Inspection

An adversarial mock inspection run against your quality system. You see the 483 the way the agency would write it, while there is still time to answer it. QMSR, ISO 13485, IVDR and MDR.

Icon

Finding Response

Responses to 483 observations, Warning Letters and Notified Body nonconformances, written to close the finding, not restate it.

Icon

Submission Review

A 510(k) reviewed the way an OPEQ reviewer reviews it, at refuse to accept and at substantive review. Deficiency risk surfaced before the submission leaves your hands.

Icon

Named Review

Every consequential output is reviewed by a qualified subject matter expert before release.

Icon

Traceable Reasoning

Reasoning, sources and limitations are visible on the output, not held behind it.

Icon

Confidential by Default

Your records stay yours. Engagements are confidential and scoped in writing.

Founder portrait placeholder — use a real portrait of Mario Wijker. No stock imagery.

“Every company hits the same problems. The expertise to solve them has never been available at the speed the work demands.”

Mario Wijker, Founder

We start with a conversation, not a pitch. And finish with a decision you can defend.

01

A private conversation

We start with what is keeping you awake before the audit. No pitch, no demo. If the fit is right, we show you exactly how we would reduce the risk you are carrying now.

02

The adversarial run

We put your evidence through the discipline that fits the decision, and give you back what a regulator would find. Every conclusion carries its source.

03

A named expert behind it

Nothing that carries our name reaches you without a person who has earned that judgment standing behind it. Where the evidence is limited, we say so.

A conversation,

not a demo.

not a demo.

Start with the evidence, the risk and the deadline. We will tell you honestly whether VIQERA can help.

A conversation,

not a demo.

not a demo.

Start with the evidence, the risk and the deadline. We will tell you honestly whether VIQERA can help.

A conversation,

not a demo.

not a demo.

Start with the evidence, the risk and the deadline. We will tell you honestly whether VIQERA can help.
VIQERA owl logo

VIQERA

mario@viqera.com · The Netherlands

VIQERA is a private partnership for medical device and IVD companies. Every engagement is confidential, and every conclusion that carries the VIQERA mark has been reviewed by a named subject-matter expert.

© 2026 VIQERA · Confidential & Proprietary

VIQERA owl logo

VIQERA

mario@viqera.com · The Netherlands

VIQERA is a private partnership for medical device and IVD companies. Every engagement is confidential, and every conclusion that carries the VIQERA mark has been reviewed by a named subject-matter expert.

© 2026 VIQERA · Confidential & Proprietary

VIQERA owl logo

VIQERA

mario@viqera.com · The Netherlands

VIQERA is a private partnership for medical device and IVD companies. Every engagement is confidential, and every conclusion that carries the VIQERA mark has been reviewed by a named subject-matter expert.

© 2026 VIQERA · Confidential & Proprietary